⌘K

Home/Insiders/Naesens Janwillem

NJ

SEC Insider//CIK 0001864377

Naesens Janwillem

CIK 00018643771 companyMEISE, C9

Transactions

9

Companies

1

Filings

3

CIK

0001864377

Recent Transactions

9 trades

Award
Cyteir Therapeutics, Inc.
Stock Option (Right to Buy)
2022-02-22+14,150→ 14,150 total
Conversion
Cyteir Therapeutics, Inc.
Common Stock
2021-06-22+3,259,026→ 3,259,026 total
Conversion
Cyteir Therapeutics, Inc.
Series B Convertible Preferred Stock
2021-06-22−10,000,000→ 0 total
Conversion
Cyteir Therapeutics, Inc.
Series C Convertible Preferred Stock
2021-06-22−1,109,368→ 0 total
Conversion
Cyteir Therapeutics, Inc.
Common Stock
2021-06-22+3,259,026→ 3,259,026 total
Purchase
Cyteir Therapeutics, Inc.
Common Stock
2021-06-22$18.00/sh+277,777→ 3,536,803 total
Purchase
Cyteir Therapeutics, Inc.
Common Stock
2021-06-22$18.00/sh+277,777→ 3,536,803 total
Conversion
Cyteir Therapeutics, Inc.
Series B Convertible Preferred Stock
2021-06-22−10,000,000→ 0 total
Conversion
Cyteir Therapeutics, Inc.
Series C Convertible Preferred Stock
2021-06-22−1,109,368→ 0 total

Companies

1

Cyteir Therapeutics, Inc.
10% Owner

Recent Filings

3

Address

BRUSSELSESTEENWEG 11

MEISE, C9, 1860

View on SEC.gov